Bone Marrow Failure Disorders

9 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Bone Marrow Failure Disorders
Treatment and conditionWhere it standsTrials
GVHD prophylaxis regimen + RIC regimen for bone marrow failure disordersPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Isatuximab for anemia, aplasticPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phase 1 Dose Level 1 + Phase 1 Dose Level 2 + Phase 1 Dose Level 3 for congenital bone marrow failure syndromesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phase 2 Established Dose from prior study, NCT03810196 for congenital bone marrow failure syndromesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phase 2 Maximum Tolerated Dose determined in Phase 1 for congenital bone marrow failure syndromesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
reduced-dose conditioning regimen containing TBI in hematopoietic stem cell transplantation treating elderly patients with aplastic anemia for anemia, aplasticTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Rivogenlecleucel + rimiducid for anemia, aplasticTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Romiplostim for anemia, aplasticPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
thrombopoietin receptor agonist (TPO-RA) + Cyclosporine + ROMIPLOSTIM for anemia, aplasticTrial registered, as of 19 Nov 2026 (not yet checked by a person)1